Unity Biotechnology Inc (UBX) Looking To Gain Traction: What the Technicals Reveal

The EU will unveil proposals for a digital tax on US tech giants on Wednesday, reported France 24. The special tax is the latest measure by the 28-nation European Union to levy fees on Silicon Valley giants and could further inflame a trade row pitting the EU against US President Donald Trump. 

As the proposed digital tax would be applied on the basis and geography of digital users, Facebook (FB) would face levies, along with Alphabet’s Google (GOOGL), and Amazon (AMZN), among others. Companies with annual revenue of less than $924 million may not face the new fees. EU Economics Affairs Commissioner Pierre Moscovici will present proposals aimed at recovering billions of euros from mainly US multinationals that shift earnings around Europe to pay lower tax rates. 

The new tax has been championed by French President Emmanuel Macron and will be discussed over dinner at an EU leaders summit on Thursday. The unprecedented tech-tax follows major anti-trust decisions by the EU that have set back Apple, Google and Amazon.

After a recent look, we have noticed that the Chaikin Oscillator is under zero for Unity Biotechnology Inc (UBX). Traders may be paying close attention to the stock and looking out for possible bearish momentum.

When dealing with the equity markets, investors are often tasked with trying to find stocks that are bound for glory. Every investor dreams of finding those stocks that were overlooked but are poised to pick up momentum. New investors are often instructed to set goals before starting to invest. Creating attainable, realistic goals can be a good starting point before digging into the investment trenches. After setting up goals considering financial status, objectives, timeframes and risk appetite, the next step may involve creating an actionable plan. Once the plan is in place, it may be extremely important to routinely monitor the performance of the portfolio. There are often many well crafted investment plans that for whatever reason don’t seem to be working out properly. Being able to evaluate and adjust the plan based on market activity may end up being the difference between a winning or losing portfolio. Being able to adapt to the fast paced and often times tumultuous market landscape can be a gigantic benefit for long-term portfolio health.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of stock price movements. The RSI was developed by J. Welles Wilder, and it oscillates between 0 and 100. Generally, the RSI is considered to be oversold when it falls below 30 and overbought when it heads above 70. RSI can be used to detect general trends as well as finding divergences and failure swings. The 14-day RSI is presently standing at 22.99, the 7-day is 16.87, and the 3-day is resting at 6.42.

We can also take a look at the Average Directional Index or ADX of Unity Biotechnology Inc (UBX). The ADX is used to measure trend strength. ADX calculations are made based on the moving average price range expansion over a specified amount of time. ADX is charted as a line with values ranging from 0 to 100. The indicator is non-directional meaning that it gauges trend strength whether the stock price is trending higher or lower. The 14-day ADX sits at 29.51. In general, and ADX value from 0-25 would represent an absent or weak trend. A value of 25-50 would indicate a strong trend. A value of 50-75 would indicate a very strong trend, and a value of 75-100 would signify an extremely strong trend.

Interested investors may be watching the Williams Percent Range or Williams %R. Williams %R is a popular technical indicator created by Larry Williams to help identify overbought and oversold situations. Investors will commonly use Williams %R in conjunction with other trend indicators to help spot possible stock turning points. Unity Biotechnology Inc (UBX)’s Williams Percent Range or 14 day Williams %R currently sits at -98.77. In general, if the indicator goes above -20, the stock may be considered overbought. Alternately, if the indicator goes below -80, this may point to the stock being oversold.

Unity Biotechnology Inc (UBX) currently has a 14-day Commodity Channel Index (CCI) of -94.02. Active investors may choose to use this technical indicator as a stock evaluation tool. Used as a coincident indicator, the CCI reading above +100 would reflect strong price action which may signal an uptrend. On the flip side, a reading below -100 may signal a downtrend reflecting weak price action. Using the CCI as a leading indicator, technical analysts may use a +100 reading as an overbought signal and a -100 reading as an oversold indicator, suggesting a trend reversal.

Moving averages can help spot trends and price reversals. They may also be used to help find support or resistance levels. Moving averages are considered to be lagging indicators meaning that they confirm trends. A certain stock may be considered to be on an uptrend if trading above a moving average and the average is sloping upward. On the other side, a stock may be considered to be in a downtrend if trading below the moving average and sloping downward. Shares of Unity Biotechnology Inc (UBX) have a 7-day moving average of 8.87.

Investors are constantly trying to make smarter decisions when it comes to dealing with the stock market. There are so many choices out there that it may become completely overwhelming at first. Starting with a baseline approach can help ease the burden of too much information. Developing the proper investment knowledge may take a lot of time and effort. Many investors may find out the hard way that shortcuts are not the answer to achieving long-term success in the stock market. Many people may occasionally get lucky and think they can do no wrong. Over time, this type of investor may see profits start to shrink and losses start to pile up. Many investors are bombarded with hot investment tips. It can be very tempting to take advice from someone who has actually made money in the markets previously. However, the old adage remains the same; past results may not indicate future results. Thinking that something that has worked in the past will no doubt work in the future can be a recipe for portfolio disaster. Individual investors who do their own thorough research should be much better positioned to make the proper decisions when the time comes.